INSIGHTS ON PHARMACEUTICAL LOGISTICS

• Risk Mitigation For Late-Stage Clinical Assets

  Leveraging the competence and capabilities of the CDMO to bring forth innovative, flexible solutions to safeguard supply chains for their clients and, ultimately, for patients is crucial to strategic partnering.

• A Temperature-Stable Replacement For Animal Trypsin In Cell Dissociation Applications

  Improve cell dissociation with a gentle, recombinant enzyme. This temperature-stable protease shows dissociation kinetics similar to porcine trypsin but with lower cell toxicity and greater overall purity.

• Top Safety Considerations In Biopharmaceutical Manufacturing

  Understanding top safety concerns, from combustible material handling and chemical exposure to HPAPIs, is the first step toward preventing accidents in biopharmaceutical manufacturing environments.

• Biopharma Supply, Reimagined: Regional, Resilient Manufacturing

  Persistent disruption is redefining biopharma supply chains. Explore how regional manufacturing, integrated risk management, and closer collaboration help build resilience and improve agility.

• Selecting An Off-Site GMP Storage Provider

  5/8/2024

  Understanding how to select a reliable off-site storage provider will empower you to ensure the integrity and accessibility of your valuable biopharmaceutical products, materials, and samples.

• Global Strategies For Resilience And Redundancy In Cell Culture Media Supply

  7/17/2025

  Ensure your cell culture media supply remains uninterrupted. Explore proactive strategies for global manufacturing equivalency and consistent media delivery.

• Unlocking The Benefits Of Customs Warehouse For Pharmaceutical Supply Chains

  4/8/2026

  Learn how leveraging a customs warehouse can streamline your supply chain, reduce VAT costs, and enhance global compliance and efficiency.

• Supply Resiliency For Bioprocessing Amid Global Volatility

  10/2/2025

  Build bioprocessing resiliency with strategic supply chain management. Learn to meet quality, compliance, and time-to-market demands amid global volatility with effective sourcing.

• Optimizing End-To-End Contract Analytical Support For Cell And Gene Therapies

  7/11/2024

  The development and production of CGTs presents unparalleled complexities. Learn how a partner with robust end-to-end services can help you overcome challenges at every step of the drug lifecycle.